Suppr超能文献

播散限制了广泛手术切除、精细随访和强化治疗复发后的间变性室管膜瘤患者的生存。

Dissemination limits the survival of patients with anaplastic ependymoma after extensive surgical resection, meticulous follow up, and intensive treatment for recurrence.

机构信息

Department of Neurosurgery, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.

出版信息

Neurosurg Rev. 2010 Apr;33(2):185-91; discussion 191-2. doi: 10.1007/s10143-010-0243-z. Epub 2010 Feb 26.

Abstract

The extent of resection is the most consistent factor affecting outcome of intracranial ependymomas. The outcomes in patients with intracranial anaplastic ependymomas who underwent more than subtotal resection and intensive treatment for recurrence were reviewed retrospectively. Between 1989 and 2007, 18 patients underwent more than subtotal resection at Tohoku University Hospital. Adjuvant chemoradiation therapy was conducted in 16 patients. Meticulous follow-up was performed for early detection of recurrence. Intensive therapy including surgery and chemoradiation therapy was added for recurrence. Median survival in all 18 patients was 136 months. The 5- and 10-year survival rates were 59.1% and 50.7%, respectively. Eight patients died during the observation period, five of dissemination, but none of uncontrollable local recurrence. High resection rate, meticulous follow-up, and intensive treatment for recurrence improved the survival of patients with anaplastic ependymoma. Dissemination was the life-determining factor in this series of patients.

摘要

切除范围是影响颅内室管膜瘤患者预后的最一致因素。回顾性分析了在东北大学医院接受超过次全切除和复发强化治疗的颅内间变性室管膜瘤患者的结果。1989 年至 2007 年间,18 名患者在东北大学医院接受了超过次全切除术。16 名患者接受了辅助放化疗。对复发进行了精心随访以早期发现。对于复发,采用手术和放化疗等强化治疗。18 名患者的中位生存期为 136 个月。5 年和 10 年生存率分别为 59.1%和 50.7%。观察期间有 8 名患者死亡,5 例为播散,但均无不可控局部复发。高切除率、精心随访和对复发的强化治疗改善了间变性室管膜瘤患者的生存。在本系列患者中,播散是决定生死的因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验